Clinical Trials Directory

Trials / Completed

CompletedNCT00597363

Neptune Pad ® Compared to Conventional Manual Compression

Neptune Pad ® Compared to Conventional Manual Compression for Access Site Management After Peripheral Percutaneous Transluminal Procedures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
201 (actual)
Sponsor
Vienna General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

BACKGROUND. Arterial access site complications remain the most frequent adverse events after percutaneous transluminal procedures. We investigated the safety and efficacy of the pro-coagulant wound dressing Neptune Pad ® compared to conventional manual compression for access site management after peripheral percutaneous interventions. METHODS. We enrolled 201 consecutive patients and randomly assigned patients for Neptune Pad ® (n=100) vs. conventional manual compression (n=101). Patients were followed clinically until hospital discharge and by duplex ultrasound at 24 hours postprocedure for occurrence of access site complications. Time-to-hemostasis and time-to-ambulation were recorded, patients´ and physicians´ discomfort were measured using a visual analogue scale.

Conditions

Interventions

TypeNameDescription
DEVICENeptune P.A.D. (R)The Neptune Pad ® (Biotronik GmbH \& Co. KG, Berlin, Germany) is a soft and hydrophilic wound dressing, which has been developed to accelerate local hemostasis, reduce compression times, enable early ambulation and minimize the risk for bleeding complications. Neptune Pad ® consists of calcium alginate, which is cationically charged and exerts potent procoagulant properties.
OTHERconventional manual compressionThe most common technique for puncture site management is manual compression. This technique requires an extended pressure on the puncture site, and after achievement of hemostasis a pressure bandage is applied for several hours at bed rest.

Timeline

Start date
2006-01-01
Primary completion
2007-09-01
Completion
2008-01-01
First posted
2008-01-18
Last updated
2008-01-18

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00597363. Inclusion in this directory is not an endorsement.